Aquatic Capital Management’s AstraZeneca AZN Stock Holding History

Aquatic Capital Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$12.9M	Buy	+68,181	New	+$12.8M	0.44%	40
2026 Q1	–	Sell	-47,033	Closed	-$8.65M	–	1368
2025 Q4	$8.65M	Buy	+47,033	New	+$8.25M	0.25%	100
2024 Q4	–	Sell	-31,657	Closed	-$4.93M	–	1333
2024 Q3	$4.93M	Buy	31,657 +20,457	+183%	+$3.3M	0.13%	195
2024 Q2	$1.75M	Sell	11,200 -3,100	-22%	-$466K	0.06%	287
2024 Q1	$1.94M	Sell	14,300 -33,550	-70%	-$4.44M	0.06%	258
2023 Q4	$6.45M	Buy	+47,850	New	+$6.22M	0.16%	142
2023 Q3	–	Sell	-27,100	Closed	-$3.88M	–	1245
2023 Q2	$3.88M	Buy	+27,100	New	+$3.99M	0.21%	113
2022 Q4	–	Sell	-78,800	Closed	-$8.64M	–	1359
2022 Q3	$8.64M	Buy	78,800 +78,700	+78,700%	+$9.98M	0.84%	13
2022 Q2	$13K	Sell	100 -150	-60%	-$19.7K	﹤0.01%	915
2022 Q1	$33K	Sell	250 -50	-17%	-$6K	0.05%	374
2021 Q4	$35K	Buy	+300	New	+$35.3K	0.07%	412

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Aquatic Capital Management's AZN Position: Q2 2026 in Review

Aquatic Capital Management opened a new position in AstraZeneca (AZN) in Q2 2026: 68,181 shares worth $12.9M. The stake represents 0.44% of the portfolio and ranks #40 among its holdings. This is a return to the name: Aquatic Capital Management previously reported a position in AZN as recently as Q4 2025.

Aquatic Capital Management first reported a position in AZN in Q4 2021 and has held it in 11 quarters since. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Aquatic Capital Management held 68,181 shares of AstraZeneca worth $12.9M as of Q2 2026.
AstraZeneca was a new Aquatic Capital Management position in Q2 2026.
AstraZeneca made up 0.44% of Aquatic Capital Management's portfolio in Q2 2026, its #40 holding.
Aquatic Capital Management first reported a position in AstraZeneca in Q4 2021 and has held it in 11 quarters since.
1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Aquatic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.